Supporting safe practices for low-dose methotrexate


This position statement aims to provide clear information on safety for those dispensing and administering low-dose methotrexate (oral and subcutaneous dosage forms) and assists them with providing reassurance to people undergoing treatment with this medicine.

There is also a  consumer ‘Safe use of low-dose methotrexate factsheet’ to help consumers use low-dose methotrexate safely

Download resource

Download (694.04 KB, PDF)

Published date

8 October 2020

Resource type

Position statements

Governance topic

Low-dose methotrexate